Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Uterine trachelectomy
What uterine trachelectomy is, how radical cervix removal preserves the uterine body for future pregnancy in early-stage cervical cancer, oncological safety and fertility evidence, candidate criteria, approximate costs in Turkey compared with the UK, US and Germany, surgical techniques, recovery milestones, risks, and how to choose an accredited gynaecological oncology hospital.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Uterine Trachelectomy
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Uterine trachelectomy: what it is and how fertility is preserved
Uterine trachelectomy (commonly termed radical trachelectomy) is a specialised surgical oncology procedure designed to treat early-stage cervical cancer without removing the body of the uterus. During the operation, a gynaecological oncologist excises the uterine cervix, the upper one to two centimetres of the vagina, and the adjacent supporting parametrial tissues. Crucially, the uterine body (corpus uteri), endometrium, fallopian tubes, and ovaries are left intact. A permanent, non-absorbable stitch called a cerclage is placed around the lower uterine segment to provide structural closure for future pregnancies. The preserved uterine body is then surgically reconnected to the upper vagina.
For young women facing a cervical malignancy who wish to retain their childbearing potential, uterine trachelectomy provides an established alternative to a radical hysterectomy. The procedure demands meticulous patient selection, advanced surgical expertise, and dedicated multidisciplinary cancer care. This guide explains how the surgery is performed, what the clinical evidence shows regarding cancer control and pregnancy, how prices in Turkey compare with the UK, US, and Germany, and what recovery entails. For an overview of surgical cancer care, see our guide to oncology treatments in Turkey.
How does a uterine trachelectomy work step by step?
A uterine trachelectomy is performed under general anaesthesia and typically takes between three and four hours. The operation can be conducted through a vaginal approach combined with laparoscopy (originally known as Dargent's procedure), through an open abdominal incision, or via minimally invasive laparoscopic or robotic methods. The intervention proceeds through systematic stages to guarantee both oncological safety and anatomical reconstruction:
- Pelvic lymph node assessment: The surgeon first inspects and removes the regional pelvic lymph nodes or performs sentinel lymph node mapping. These nodes are examined immediately by a pathologist using rapid frozen-section analysis. If cancer cells are detected in the lymph nodes, the trachelectomy is halted, and treatment shifts to standard chemoradiotherapy or comprehensive surgery.
- Parametrial and cervical excision: Once lymph nodes are confirmed clear, the surgeon mobilises the bladder and ureters to safely excise the cervix and the surrounding parametrial tissue with adequate margins.
- Margin verification: The excised cervix is sent for intraoperative frozen-section evaluation. The upper surgical margin at the lower uterine segment must show at least five millimetres of healthy, tumour-free tissue before reconstruction proceeds.
- Prophylactic cerclage placement: A permanent synthetic band (such as a Mersilene tape or heavy polypropylene suture) is tied securely around the isthmus of the uterus to act as an artificial cervix during future gestations.
- Uterovaginal anastomosis: The remaining uterine body is sutured directly to the upper vaginal vault to establish a continuous reproductive tract, allowing normal menstrual flow to exit.
Does uterine trachelectomy work? Oncological safety and fertility evidence
Clinical data gathered over three decades demonstrate that uterine trachelectomy provides oncological outcomes equivalent to radical hysterectomy when strict eligibility criteria are met. Major international bodies, including the European Society of Gynaecological Oncology (ESGO), the Royal College of Obstetricians and Gynaecologists (RCOG), and the National Comprehensive Cancer Network (NCCN), recognise radical trachelectomy as a standard fertility-sparing treatment for early-stage cervical carcinoma. In patients with tumours measuring two centimetres or less and negative lymph nodes, five-year recurrence rates remain low at approximately three to five per cent, with overall survival exceeding 95 per cent.
Just as organ-preserving resections like lumpectomy in breast cancer care aim to excise tumours while maintaining normal anatomy, trachelectomy provides oncological clearance while retaining the uterine body. Fertility outcomes are similarly encouraging: approximately 70 per cent of women who attempt conception after recovering from surgery successfully become pregnant. However, patients must understand that these pregnancies carry heightened risks of second-trimester loss and preterm delivery due to the absence of the cervical canal, and all deliveries require a planned caesarean section.
Uterine trachelectomy cost in Turkey compared with the UK, US and Germany
The cost of uterine trachelectomy varies according to the surgical approach (open abdominal, vaginal, or robotic-assisted), the complexity of pelvic lymphadenectomy, pre-operative staging requirements, and the length of inpatient hospital stay. The figures in the table below reflect broad, realistic price ranges across different healthcare systems, rather than hospital-specific quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €6,000 – €14,000 |
| United Kingdom | €16,000 – €32,000 |
| United States | €30,000 – €70,000 |
| Germany | €14,000 – €28,000 |
Several clinical elements influence the total uterine trachelectomy price. These include specialised pre-operative imaging such as pelvic MRI and PET-CT scans, multidisciplinary tumour board consultations, intraoperative frozen-section histology, hospital stay length (usually three to five nights), and follow-up pathology tests. In Turkey, treatment packages typically bundle the surgeon and anaesthetist fees, hospital accommodation, nursing care, routine surgical medications, histopathology, bilingual patient coordination, and airport transfers. You can request an individualised breakdown through our free quote service before making any financial commitment.
Uterine trachelectomy, radical hysterectomy or conisation?
Surgical management of cervical lesions depends directly on the disease stage, depth of invasion, and the patient's personal family plans. Uterine trachelectomy occupies a distinct middle ground between simple local excisions and definitive non-fertility operations.
| Method | Best suited to | Typical limits |
|---|---|---|
| Uterine trachelectomy | Stage IA2–IB1 cervical tumours measuring 2 cm or less in women wishing to preserve fertility | Inappropriate for tumours over 2 cm, deep stromal invasion, or positive lymph nodes |
| Radical hysterectomy | Early-stage cervical cancer where childbearing is complete or not desired, or tumours exceeding trachelectomy criteria | Permanent loss of childbearing capacity through complete removal of the uterus |
| Cervical conisation | Microinvasive stage IA1 cervical cancer without vascular space invasion, or severe cervical dysplasia (CIN 3) | Insufficient tissue clearance and lacks parametrial or nodal resection for stage IB1 disease |
Cone biopsy (conisation) removes only a cone-shaped fragment of the cervix; while preserving fertility, it provides insufficient margin width and zero lymph node staging for visible invasive tumours. Conversely, radical hysterectomy removes the entire organ, eliminating any prospect of pregnancy. A qualified gynaecological oncologist will evaluate your histological slides and imaging to recommend the safest option for your condition.
Who is a suitable candidate for uterine trachelectomy?
Stringent patient selection is essential to maintain high cure rates. A suitable candidate typically meets the following medical criteria:
- A confirmed histological diagnosis of squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the cervix.
- FIGO 2018 staging classified as Stage IA2 or Stage IB1 (rarely selected Stage IA1 with extensive lymphovascular space invasion).
- A maximum tumour diameter of two centimetres or smaller on clinical examination and high-resolution pelvic MRI.
- Tumour location confined to the exocervix or lower endocervix, leaving at least five to eight millimetres of healthy endocervical tissue below the internal os.
- No evidence of pelvic or para-aortic lymph node metastases on imaging or frozen-section biopsy.
- An active, expressed desire to preserve fertility and a clear understanding of obstetric risks.
Patients are not suitable for uterine trachelectomy if their tumour exceeds two centimetres, if cancer has infiltrated the upper endocervix or uterine corpus, or if lymph nodes contain malignant cells. Furthermore, uncommon aggressive subtypes such as small-cell neuroendocrine carcinoma, gastric-type adenocarcinoma, or sarcoma are unsuitable for fertility preservation because of their high propensity for systemic spread.
Pregnancy and life after uterine trachelectomy: what to expect
Following a successful operation, normal menstruation typically resumes within one to three months. Most oncologists advise waiting between 6 and 12 months before attempting to conceive. This waiting period allows internal tissues to heal, reduces local inflammation, and covers the initial post-operative surveillance window when early recurrences are most detectable.
Many women conceive naturally, although some may require assisted reproductive techniques such as intrauterine insemination (IUI) or in vitro fertilisation (IVF), particularly if cervical stenosis occurs or cervical mucus production is reduced. Because the cervix is no longer present to act as a barrier, every pregnancy after trachelectomy must be managed by a maternal-fetal medicine specialist. The prophylactic cerclage supports the lower uterine segment, but risks of mid-trimester miscarriage and premature rupture of membranes remain higher than average. To protect the cerclage and prevent catastrophic uterine tearing, vaginal birth is completely ruled out: every delivery must take place by planned caesarean section at 36 to 38 weeks.
Travel to Turkey and recovery milestones after uterine trachelectomy
Undergoing a uterine trachelectomy in Turkey generally requires a total stay of 12 to 16 days. This timeframe allows your oncology team to conduct pre-operative imaging, hold a tumour board discussion, complete the surgery, oversee initial wound healing, and conduct post-operative reviews before certifying you fit to fly home. Recovery follows a predictable progression:
- Days 1 to 4 (Inpatient stay): You spend the first three to five days in hospital. Pain management is delivered intravenously before transitioning to oral tablets. A urinary catheter remains in place while normal bladder function is monitored, and gentle walking is encouraged to prevent blood clots.
- Weeks 1 to 2: After discharge to your hotel, you attend outpatient checks. The catheter is removed once bladder emptying is satisfactory. The surgical team inspects the vaginal and abdominal incisions and reviews final permanent histology results.
- Weeks 3 to 6: You may gradually resume light daily routines and seated desk work. Vigorous exercise, heavy lifting, tub baths, swimming, and sexual intercourse must be strictly avoided for at least eight to twelve weeks.
- Month 3 onwards: Your first comprehensive follow-up takes place, including a pelvic examination, colposcopy, and review with your local gynaecologist.
Rigorous staging and histological assessment mirror the precision required in complex gastrointestinal resections, such as the removal of colon cancer, where clear margins and regional node evaluations define long-term survival.
Risks and complications of uterine trachelectomy
As with any radical pelvic cancer surgery, uterine trachelectomy carries recognised medical and surgical risks. Immediate surgical risks include intraoperative bleeding requiring transfusion, wound infection, deep vein thrombosis, and accidental injury to adjacent structures such as the ureters, bladder, or bowel. Disruption of autonomic nerve fibres around the cervix can cause temporary urinary retention, meaning some patients require a urinary catheter for one to two weeks following surgery.
Medium- and long-term anatomical complications include neocervical stenosis (narrowing of the opening into the uterus), which can cause painful periods (dysmenorrhoea) or difficulty conceiving. In such cases, gentle cervical dilation may be required. Obstetric risks include cervical incompetence, chorioamnionitis, and preterm delivery. Oncologically, there remains a three to five per cent risk of cancer recurrence. If recurrent disease develops, standard salvage management involves completion radical hysterectomy, pelvic radiotherapy, and systemic chemotherapy. The European Society of Gynaecological Oncology (ESGO) emphasizes that radical trachelectomy must only be undertaken by subspecialist oncological surgeons operating in high-volume cancer centres.
How to choose a gynaecological oncology hospital and red flags
When selecting a hospital for a uterine trachelectomy abroad, verify that the facility operates a certified Gynaecological Oncology department rather than general gynaecology. The hospital should feature an active Multidisciplinary Tumour Board (MDT) where gynaecological oncologists, medical oncologists, radiologists, and pathologists jointly evaluate every patient file. On-site, 24-hour frozen-section pathology is an absolute necessity, as node and margin clearance must be proven while you are asleep on the operating table.
Critical red flags include any surgeon willing to schedule a trachelectomy without requesting high-resolution pelvic MRI scans, offering the procedure for tumours larger than two centimetres, or promising guaranteed cure or pregnancy rates. Be cautious of providers that do not identify the operating surgeon by name or cannot outline a clear post-operative emergency pathway. Review how it works to understand how pathology reports, imaging scans and surgical evaluations are coordinated across international borders.
Key questions to ask your surgical oncology team
Before proceeding with treatment, ensure you discuss these essential points with your prospective surgical team:
- Has my biopsy and pelvic MRI confirmed that my cervical tumour is two centimetres or less in diameter?
- Will my case be formally presented and reviewed at your hospital's multidisciplinary tumour board?
- Which surgical approach (vaginal, abdominal, or robotic) do you recommend for my anatomy, and what are your reasons?
- Is intraoperative frozen-section pathology available during surgery to check lymph nodes and upper resection margins?
- How many radical trachelectomy procedures has your surgical team completed over the past three years?
- What material is used for the permanent cerclage stitch, and how is it secured?
- How will my bladder function be assessed before the urinary catheter is removed?
- What specific documentation and pathology reports will I receive to take back to my home oncologist?
- What is the recommended surveillance schedule for colposcopy, cytology, and imaging once I return home?
To begin an initial assessment with an accredited gynaecological oncology team, visit our free quote page to submit your medical reports securely.
Hospitals with Oncology in Turkey
Frequently asked questions
A uterine trachelectomy, or radical trachelectomy, is a specialised fertility-preserving operation for early-stage cervical cancer. The surgeon removes the cervix, the surrounding parametrial tissue and the upper vaginal cuff, while leaving the uterine body, fallopian tubes and ovaries intact. A permanent stitch is placed around the lower uterus to support future pregnancies, which must be delivered by planned caesarean section.
Yes, for carefully selected patients with early-stage disease. Clinical studies and gynaecological oncology registries show that when tumours measure two centimetres or less without lymph node involvement, recurrence rates after trachelectomy are comparable to radical hysterectomy. Five-year disease-free survival remains between 95 and 97 per cent under strict international criteria.
Approximate treatment costs in Turkey range from €6,000 to €14,000, compared with €16,000 to €32,000 in the UK and upwards of €30,000 in the US. The price covers pre-operative staging scans, tumour board review, the surgical procedure, lymph node assessment, hospital admission and pathology testing. The hospital confirms an exact price in a written quote.
Before surgery, patients undergo thorough staging with pelvic MRI and tumour board review. After surgery, normal menstrual periods usually resume within one to three months. While sexual intercourse and strenuous exercise pause for two to three months, long-term physical function is preserved, and conception can be pursued once initial cancer surveillance is complete.
Most patients remain in hospital for three to five days and stay in Turkey for 12 to 16 days. Desk work can often resume after four to six weeks, while full physical recovery and healing of the uterovaginal junction take eight to twelve weeks. Conception is typically deferred for 6 to 12 months.
General anaesthesia ensures you feel nothing during the operation. Post-operative discomfort is managed with intravenous and oral analgesia. Patients generally experience pelvic cramping, lower abdominal soreness and temporary bladder discomfort from the catheter, which settle noticeably during the first two weeks as internal inflammation subsides.
When margins and lymph nodes are completely clear, long-term cancer-free survival matches that of radical hysterectomy. Most recurrences, if they occur, happen within the first two to three years, which is why regular surveillance with colposcopy, cytology and MRI scans every three to six months is essential during the initial post-operative years.
Cervical conisation removes only a small cone of cervical tissue and is limited to pre-cancerous dysplasia or microscopic stage IA1 disease. Trachelectomy is a radical cancer operation that removes the entire cervix, adjacent parametrial tissue and pelvic lymph nodes, providing cancer clearance for invasive stage IA2 and IB1 tumours while preserving the uterus.
Conception can occur naturally or with assisted reproductive technology, but pregnancy carries higher risks of cervical weakness and premature birth. The permanent cervical stitch supports the uterus during gestation. Because the cervix is absent, all deliveries must be carried out by planned caesarean section to protect maternal and neonatal health.
Plan to spend 12 to 16 days in Turkey. This window accommodates pre-operative consultations, imaging, tumour board evaluation, three to five days of hospital inpatient care, catheter removal and post-operative surgical reviews. Your gynaecological oncologist must confirm that healing is satisfactory before issuing a fit-to-fly certificate.
Patient stories